Publication | Closed Access

Sorafenib inhibits nuclear factor kappa B, decreases inducible nitric oxide synthase and cyclooxygenase-2 expression, and restores working memory in APPswe mice

Neurodegenerative DiseasesCyclooxygenase-2 ExpressionMedicineNeuropharmacologyNeuroprotectionNeuroscienceAppswe MicePharmacologyCell BiologyCell SignalingOxidative StressNeuroinflammation